Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Shares Outstanding (Weighted Average): 2022-2024

Historic Shares Outstanding (Weighted Average) for Prime Medicine (PRME) over the last 3 years, with Dec 2024 value amounting to $131.2 million.

  • Prime Medicine's Shares Outstanding (Weighted Average) rose 12.12% to $134.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.6 million, marking a year-over-year increase of 12.12%. This contributed to the annual value of $131.2 million for FY2024, which is 34.77% up from last year.
  • According to the latest figures from FY2024, Prime Medicine's Shares Outstanding (Weighted Average) is $131.2 million, which was up 34.77% from $97.3 million recorded in FY2023.
  • Prime Medicine's Shares Outstanding (Weighted Average)'s 5-year high stood at $131.2 million during FY2024, with a 5-year trough of $97.2 million in FY2022.
  • Over the past 3 years, Prime Medicine's median Shares Outstanding (Weighted Average) value was $97.3 million (recorded in 2023), while the average stood at $108.6 million.
  • Data for Prime Medicine's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 34.77% (in 2024) over the last 5 years.
  • Over the past 3 years, Prime Medicine's Shares Outstanding (Weighted Average) (Yearly) stood at $97.2 million in 2022, then rose by 0.12% to $97.3 million in 2023, then soared by 34.77% to $131.2 million in 2024.